Detail
LncRNA Name | BALR-6 |
Synonyms | NA |
Region | NA Sequence |
Ensembl | NA |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | B-lymphoblastic leukemia |
ICD-0-3 | M9811/3 |
Methods | qPCR, RNAi, Northern blot etc. |
Sample | cell lines (MV, Reh, 697, Nalm-6, 70Z/3, HEK 293) |
Expression Pattern | up-regulated |
Function Description | Overexpression of BALR-6 in murine bone marrow transplantation experiments caused a significant increase in early hematopoietic progenitor populations, suggesting that its dysregulation may cause developmental changes. Notably, the knockdown of BALR-6 resulted in global dysregulation of gene expression. The gene set was enriched for leukemia-associated genes, as well as for the transcriptome regulated by Specificity Protein 1 (SP1). We confirmed changes in the expression of SP1, as well as its known interactor and downstream target CREB1. Luciferase reporter assays demonstrated an enhancement of SP1-mediated transcription in the presence of BALR-6. These data provide a putative mechanism for regulation by BALR-6 in B-ALL |
Pubmed ID | 26694754 |
Year | 2015 |
Title | BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia |
External Links |
Links for BALR-6 | GenBank HGNC lncrnadb Noncode |
Links for B-lymphoblastic leukemia | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.